The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to...

With an exclusive partnership with EBD Group, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early stage innovations in the field of Life Sciences. BioFIT is also the marketplace for seed and Series A investment in Life Sciences. 25% discount on registration for United Life Sciences members. For more...

Biolatam is the biotechnology conference which provides unique access to Latin America, one of the fastest growing life science markets, in a forum for collaboration, discussion and partnering among key industry executives in Latin America, the US and Europe. International drug developers are increasingly targeting Latin America's emerging market and innovative capabilities in generic pharmaceuticals,...

Building on the success of our 2nd Annual Neuroscience BioPartnering & Investment Forum we are pleased to announce The Neuroscience & Technology Innovation Forum to take place at Marines' Memorial Club, San Francisco on the 7th of January 2018, a day before the JP Morgan meeting. The program will cover BioPartnering for CNS, with industry...

Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry's largest annual healthcare investor conferences. Hear from 400 public and private biotechnology...

The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring...

The Middle East healthcare business is expected to be worth $60 billion by 2025 as the need for investment in services and facilities increases. It is one of the few regions in the world that faces such a rapid increase in demand and this growth is creating new opportunities in the healthcare sector. The Arab...

Innovation for Health is the Netherlands´ premier conference for innovators in Health and Life Sciences. This is the place where key players in health and care, from bench to boardroom, from start-up to multinational, from Life Sciences to Medtech, come to strengthen existing contacts and to expand their networks and knowledge. With more than 800 delegates,...

Join over 3,700 drug discovery and development professionals worldwide at the 25th International Molecular Medicine Tri-Conference! Since its debut in 1993, the annual Molecular Medicine Tri-Conference has become one of the world's leading international events in the field of drug discovery, development and diagnostics. The Tri-Conference unites an ecosystem of 3,700 innovative thinkers and thought...

The 11th Annual ELSCEO Forum & Exhibition, is being held on 26th-27th February 2017 at the Hilton Zurich Airport Hotel, Switzerland. This event will be highly transactional, bringing together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders. We expect over 350 delegates and 70+ presenting companies. 10%...